维普中文期刊产品整合服务
意见 帮助
基本检索 作者索引 机构索引 期刊索引
  • 哲学宗教
  • 社会学
  • 政治法律
  • 军事
  • 经济管理
  • 文化科学
  • 语言文字
  • 文学
  • 艺术
  • 历史地理
  • 自然科学总论
  • 理学
  • 天文地球
  • 生物学
  • 医药卫生
  • 农业科学
  • 一般工业技术
  • 矿业工程
  • 石油与天然气工程
  • 冶金工程
  • 金属学及工艺
  • 机械工程
  • 兵器科学与技术
  • 动力工程及工程热...
  • 核科学技术
  • 电气工程
  • 电子电信
  • 自动化与计算机技术
  • 化学工程
  • 轻工技术与工程
  • 建筑科学
  • 水利工程
  • 交通运输工程
  • 航空宇航科学技术
  • 环境科学与工程
时间 1989 - 2010 学科选择学科
题名/关键词 模糊
与 题名/关键词 模糊
重新搜索 在结果中搜索
14篇 您的检索式：作者名="Ruff EM"
选中 清除  导出 查看参考文献 查看引证文献 引用追踪 共1页 首页 上一页 第1页 下一页 末页 /1 跳转
    题名 作者 年代 出处 被引量
1Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effec- tive aNticoaGulation with factor xA next GEneration in Atrial Fi- briliation-Thrombolysis In Myocardial Infarction study 48 ( EN- GAGE AF-TIMI48)显示文摘RUFF CT GIUGLIANO RP ANTMAN EM 2010Am Heart J2010，160，4：1
2Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: de- sign and rationale for the Effective aNticoagulation with factor xA next Genera- Lion in Atrial Fibrillation Thmmbolysis In myocardial Infarction study 48 ( EN- ?-AGE AF-TIMI 48) 显示文摘Ruff CT Giugliano RP Antman EM 2010Am Heart J2010，160，4：1
3Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIM1 48) 显示文摘Ruff CT Giugliano RP Antman EM 2010Am Heart J2010，160，4：1
4Evaluation of the novel factor Xa inbibitor edoxaban compared with warfarin in patients with atrial fibrillation:design and rationale for the Effective a Nticoa Gulation with x A next Generation in Atrial FibrillationThrombolysis In Myocardial Infarction study 48(ENGAGE AF-TIMI48)显示文摘Ruff CT Giugliano RP Antman EM 2010Am Heart J2010，160，4：1
5Evaluation of the novel factor Ⅹ a inhibitor edoxaban compared with warfarin in patients with atrial fibrillation:design and rationale for the Effective aNticoaGlulation with factor xA next Generation in A trial Fibrillation Thrombolysis in Myocardial infarction study 48 (ENGAGE AF-TIMI 48)显示文摘Ruff CT Giugliano RP Antman EM 2010Am Heart J2010，160，4：1
6Evaluation of the novel factor X a inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48 ) 显示文摘Ruff CT Giugliano RP Antman EM 2010Am Heart J2010，160，4：1
7Evaluation of the novel factor Xa inbibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective a Nticoa Gulation with xA next Generation in Atrial Fibrillation- Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI48 ) 显示文摘Ruff CT Giugliano RP Antman EM 2010Am Heart J2010，160，4：1
8Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation:design and rationale for the Effective aNticoaGulation with factor xA next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48)显示文摘Ruff CT Giugliano RP Antman EM 2010Am Heart J2010，160，：1
9Cytotoxie effects of temoaolomide and radiation are additive-and schedule- dependent显示文摘Chalmers AJ Ruff EM Martindale C 2009International Journal of Radiation Oncology Biology Physics2009，75，5：1
10Evaluation of the novel fac-tor Xa inhibitor edoxaban compared with warfarin in patients with atri-al fibrillation:design and rationale for the Effective aNticoagGulation with factor xA next GEneration in Atrial Fibrillation-Thrombosis In Myocardial Infar显示文摘Ruff CT Giugliano RP Antman EM 0，，：1
11Cytotoxic effects of temozolomide and radiation are additive-and schedule-dependent显示文摘Chalmers AJ Ruff EM Martindale C 0，，：1
12Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective anticoagulation with factor Xa next generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48)显示文摘Ruff CT Giugliano RP Antman EM 2010Am Heart J2010，160，：1
13Evaluation of the novel factor X a inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillatlon-Thrombolysls in Myocardial Infarction study 48 (ENGAGE AF-TIMI 48)显示文摘Ruff CT Giugliano RP Antman EM 2010Am Heart J2010，160，4：1
14Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation : de- sign and rationale for the Effective aNticoaGulation with factor xA next GEnera- tion in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 ( EN- GAGE AF-TIMI 48) 显示文摘Ruff CT Giugliano RP Antman EM 2010Am Heart J2010，160，63：1
返回顶部 每页显示：
共1页 首页 上一页 第1页 下一页 末页 /1 跳转
goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费